Form 4 for MRNA Moderna
Accepted 2026-03-03 00:00:00 ET · period of report 2026-02-27 · accession 0001682852-26-000040 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-03-03 | 2026-03-02 | MRNA | Klinger Shannon Thyme | CLO | S - Sale+OE | $52.29 | -13.9K | 59.7K | -19% | -$726.0K |
| DM | 2026-03-03 | 2026-02-27 | MRNA | Klinger Shannon Thyme | CLO | F - Tax | $51.71 | -4,837 | 54.8K | -8% | -$250.1K |
| DM | 2026-03-03 | 2026-02-27+ | MRNA | Klinger Shannon Thyme | CLO | M - OptEx | $30.96 | +23.9K | 55.0K | +77% | +$739.4K |
| DM | 2026-03-03 | 2026-03-01 | MRNA | Klinger Shannon Thyme | CLO | A - Grant | $0.00 | +67.8K | 38.6K | New | $0 |
| DM | 2026-03-03 | 2026-02-27+ | MRNA | Klinger Shannon Thyme | CLO | M - OptEx | $0.00 | -23.9K | 6,189 | -79% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-03-02 | S | D | 13,885 | $52.29 | 59,689 | D | — | — | |
| 2 | Common | Common Stock | 2026-02-27 | F | D | 4,189 | $51.71 | 59,689 | D | — | — | |
| 3 | Common | Common Stock | 2026-03-02 | M | A | 13,885 | $30.96 | 73,574 | D | — | — | |
| 4 | Common | Common Stock | 2026-02-27 | M | A | 8,663 | — | 63,878 | D | — | — | (F1) Restricted stock units convert into common stock on a one-for-one basis. |
| 5 | Common | Common Stock | 2026-02-27 | F | D | 375 | $51.71 | 55,215 | D | — | — | |
| 6 | Common | Common Stock | 2026-02-27 | M | A | 774 | — | 55,590 | D | — | — | (F1) Restricted stock units convert into common stock on a one-for-one basis. |
| 7 | Common | Common Stock | 2026-02-27 | M | A | 233 | — | 54,760 | D | — | — | (F1) Restricted stock units convert into common stock on a one-for-one basis. |
| 8 | Common | Common Stock | 2026-02-27 | F | D | 113 | $51.71 | 54,647 | D | — | — | |
| 9 | Common | Common Stock | 2026-02-27 | M | A | 329 | — | 54,976 | D | — | — | (F1) Restricted stock units convert into common stock on a one-for-one basis. |
| 10 | Common | Common Stock | 2026-02-27 | F | D | 160 | $51.71 | 54,816 | D | — | — | |
| 11 | Derivative | Stock Option (Right to Buy) | 2026-03-01 | A | A | 29,275 | $0.00 | 29,275 | D | $53.57 · 2027-03-01 to 2036-03-01 | 29,275 Common Stock | (F8) 25% of this option will vest and become exercisable on March 1, 2027 with the remainder vesting in twelve (12) equal quarterly installments thereafter. |
| 12 | Derivative | Restricted Stock Units | 2026-02-27 | M | D | 8,663 | $0.00 | 25,992 | D | — · — to — | 8,663 Common Stock | (F1) Restricted stock units convert into common stock on a one-for-one basis. (F7) 25% of the shares subject to this restricted stock unit award vested on March 1, 2026 with the remainder vesting in twelve (12) equal quarterly installments thereafter. |
| 13 | Derivative | Restricted Stock Units | 2026-03-01 | A | A | 38,553 | $0.00 | 38,553 | D | — · — to — | 38,553 Common Stock | (F1) Restricted stock units convert into common stock on a one-for-one basis. (F9) 25% of the shares subject to this restricted stock unit award will vest on March 1, 2027 with the remainder vesting in twelve (12) equal quarterly installments thereafter. |
| 14 | Derivative | Stock Option (Right to Buy) | 2026-03-02 | M | D | 13,885 | $0.00 | 41,658 | D | $30.96 · 2026-03-01 to 2035-03-01 | 13,885 Common Stock | (F10) 25% of this option vested and became exercisable on March 1, 2026 with the remainder vesting in twelve (12) equal quarterly installments thereafter. |
| 15 | Derivative | Restricted Stock Units | 2026-02-27 | M | D | 233 | $0.00 | 0 | D | — · — to — | 233 Common Stock | (F1) Restricted stock units convert into common stock on a one-for-one basis. (F4) 25% of the shares subject to this restricted stock unit award vested on March 1, 2023 with the remainder vesting in twelve (12) equal quarterly installments thereafter. |
| 16 | Derivative | Restricted Stock Units | 2026-02-27 | M | D | 329 | $0.00 | 1,315 | D | — · — to — | 329 Common Stock | (F1) Restricted stock units convert into common stock on a one-for-one basis. (F5) 25% of the shares subject to this restricted stock unit award vested on February 28, 2024 with the remainder vesting in twelve (12) equal quarterly installments thereafter. |
| 17 | Derivative | Restricted Stock Units | 2026-02-27 | M | D | 774 | $0.00 | 6,189 | D | — · — to — | 774 Common Stock | (F1) Restricted stock units convert into common stock on a one-for-one basis. (F6) 25% of the shares subject to this restricted stock unit award vested on February 27, 2025 with the remainder vesting in twelve (12) equal quarterly installments thereafter. |